EMPLOYMENT AGREEMENTEmployment Agreement • October 20th, 2022 • Exagen Inc. • Services-medical laboratories • California
This Employment Agreement (this “Agreement”) is effective as of October 16, 2022 (the “Effective Date”) by and between Exagen, Inc. (the “Company”), a Delaware corporation, and John Aballi (“Executive”). References below to the “Company” shall include its subsidiaries and affiliates when applicable.
SEVERANCE AGREEMENTSeverance Agreement • October 20th, 2022 • Exagen Inc. • Services-medical laboratories • California
The purpose of this Severance Agreement (the “Severance Agreement”) is to set forth the terms of your separation from Exagen, Inc. (the “Company”). Payment of the Separation Pay described below is contingent on your agreement to and compliance with the terms of this Severance Agreement. Neither this offer to you nor the Company’s entering into this Severance Agreement shall constitute an admission by the Company. This Severance Agreement is provided pursuant to the Amended and Restated Executive Change in Control and Severance Plan, effective as of April 25, 2022 (the “Plan”), your participation in which was confirmed on June 8, 2022 (the “Participation Agreement”).
